Neurocrine Biosciences (NBIX) Misses Q1 EPS by 16c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $150.82 -3.62%
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q1 EPS of ($0.90), $0.16 worse than the analyst estimate of ($0.74). Non revenues reported.
"The Company did not report any revenue for the first quarter of 2017 compared to $15.0 million of revenue for the first quarter of 2016, which represented a milestone payment from AbbVie related to the commencement of Phase III studies of elagolix in uterine fibroids.."
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
